ĀÜĄņĀŅĀ×

Dr. William serves as Managing Partner and Chief Investment Officer of Logos Capital, a global life science investment fund focused on private/public therapeutic innovation. Prior to founding Logos, Dr. William was an investment professional at Farallon Capital Management, where he helped grow the development of Farallonā€™s biopharma portfolio. Dr. William holds an MD from Harvard Medical School, where he was a Gerald S. Foster Scholar, an MBA from Stanfordā€™s Graduate School of Business, and a BS with Honors in Biology from Stanford University. Dr. William currently serves on the board of Design Therapeutics (NASDAQ: DSGN) and is a board observer on Odyssey Therapeutics.